Skip to content
Baker Capital StrategiesMARKETS. FILINGS. PERSPECTIVE.
Powered by THEMA

BAKER CAPITAL STRATEGIES

Get the free weekly BCS email.

Selected company filings and market updates, delivered by email. Your first report will follow soon.

  • Your weekly BCS reportMarket updates and links to filings you can explore.
  • THEMA at launchWe’ll send directions for setting up your filing alerts when THEMA officially opens.

One signup for the weekly email and your free THEMA Basic account at launch.

Already registered or a CSW member?Log in to THEMA →

At least 8 characters. This also creates your free THEMA account for launch.

You’re signing up for the weekly BCS email and THEMA launch/setup updates. Unsubscribe using the link in any email. Privacy policy · Terms

BCS

Security

Fate Therapeutics, Inc. Common Stock · FATE

FATENASDAQCommon stockCurrentCIK 1434316Updated Nov 14, 2026

Company: FATE THERAPEUTICS INC →

FATE price & chart

Provider market data

Loading TradingView…

NASDAQ:FATE on TradingView ↗

TradingView · Data may be delayed

About the company

Human induced pluripotent stem cells (iPSCs) possess the unique dual properties of unlimited self-renewal and differentiation potential into all cell types of the body. The Company’s proprietary iPSC product platform combines multiplexed-engineering of human iPSCs with single-cell selection to create clonal master iPSC lines. Analogous to master cell lines used to mass produce biopharmaceutical drug products such as monoclonal antibodies, the Company utilizes its clonal master iPSC lines as a starting cell source to manufacture engineered cell products which are well-defined and uniform in composition, can be stored in inventory for off-the-shelf availability, can be administered in combination with other therapies, and can potentially reach a broad patient population. As a result, the Company’s platform is uniquely designed to overcome numerous limitations associated with patient- and donor-sourced cell therapies. Fate Therapeutics’ iPSC product platform is supported by an intellectual property portfolio of over 500 issued patents and 500 pending patent applications.

8-K · 2026-11-05 · 0001193125-26-448530

Company description from the cited filing.

In the news

Seeking Alpha

Financials

FY 2025 · USD
Revenue6,646,000USD · FY 2025
Source

10-K · 2026-02-26 · 0001193125-26-073699

2025-01-01 to 2025-12-31

Net income-136,315,000USD · FY 2025
Source

10-K · 2026-02-26 · 0001193125-26-073699

2025-01-01 to 2025-12-31

Operating income-147,704,000USD · FY 2025
Source

10-K · 2026-02-26 · 0001193125-26-073699

2025-01-01 to 2025-12-31

Diluted EPS-1.15USD per share · FY 2025
Source

10-K · 2026-02-26 · 0001193125-26-073699

2025-01-01 to 2025-12-31

Some figures are unavailable for this reporting year.

balance sheet · annual statements
Line itemQ3 2025Q3 2024Q2 2026Q2 2025Q2 2024Q1 2026Q1 2025Q1 2024FY 2025FY 2024FY 2023FY 2022
ASSETS
AssetsUSD343,671,000
Source

10-Q · 2025-11-13 · 0001193125-25-279096

As of 2025-09-30

494,970,000
Source

10-Q · 2024-11-12 · 0000950170-24-125317

As of 2024-09-30

260,103,000
Source

10-Q · 2026-08-13 · 0001193125-26-347988

As of 2026-06-30

371,632,000
Source

10-Q · 2025-08-12 · 0000950170-25-107309

As of 2025-06-30

528,817,000
Source

10-Q · 2024-08-13 · 0000950170-24-096187

As of 2024-06-30

284,916,000
Source

10-Q · 2026-05-13 · 0001193125-26-220696

As of 2026-03-31

398,670,000
Source

10-Q · 2025-05-13 · 0000950170-25-070285

As of 2025-03-31

569,892,000
Source

10-Q · 2024-05-09 · 0000950170-24-056869

As of 2024-03-31

318,937,000
Source

10-K · 2026-02-26 · 0001193125-26-073699

As of 2025-12-31

440,694,000
Source

10-K · 2025-03-05 · 0000950170-25-033510

As of 2024-12-31

506,217,000
Source

10-K · 2024-02-26 · 0000950170-24-020158

As of 2023-12-31

705,561,000
Source

10-K · 2023-02-28 · 0000950170-23-005067

As of 2022-12-31

Property, Plant and Equipment, NetUSD59,475,000
Source

10-Q · 2025-11-13 · 0001193125-25-279096

As of 2025-09-30

82,392,000
Source

10-Q · 2024-11-12 · 0000950170-24-125317

As of 2024-09-30

51,546,000
Source

10-Q · 2026-08-13 · 0001193125-26-347988

As of 2026-06-30

61,097,000
Source

10-Q · 2025-08-12 · 0000950170-25-107309

As of 2025-06-30

87,534,000
Source

10-Q · 2024-08-13 · 0000950170-24-096187

As of 2024-06-30

54,262,000
Source

10-Q · 2026-05-13 · 0001193125-26-220696

As of 2026-03-31

62,762,000
Source

10-Q · 2025-05-13 · 0000950170-25-070285

As of 2025-03-31

92,116,000
Source

10-Q · 2024-05-09 · 0000950170-24-056869

As of 2024-03-31

56,925,000
Source

10-K · 2026-02-26 · 0001193125-26-073699

As of 2025-12-31

64,384,000
Source

10-K · 2025-03-05 · 0000950170-25-033510

As of 2024-12-31

96,836,000
Source

10-K · 2024-02-26 · 0000950170-24-020158

As of 2023-12-31

110,020,000
Source

10-K · 2023-02-28 · 0000950170-23-005067

As of 2022-12-31

Current assets:
Cash and Cash Equivalents, at Carrying ValueUSD40,622,000
Source

10-Q · 2025-11-13 · 0001193125-25-279096

As of 2025-09-30

37,909,000
Source

10-Q · 2025-11-13 · 0001193125-25-279096

As of 2024-09-30

32,429,000
Source

10-Q · 2026-08-13 · 0001193125-26-347988

As of 2026-06-30

41,249,000
Source

10-Q · 2026-08-13 · 0001193125-26-347988

As of 2025-06-30

36,917,000
Source

10-Q · 2025-08-12 · 0000950170-25-107309

As of 2024-06-30

39,570,000
Source

10-Q · 2026-05-13 · 0001193125-26-220696

As of 2026-03-31

44,920,000
Source

10-Q · 2026-05-13 · 0001193125-26-220696

As of 2025-03-31

121,322,000
Source

10-Q · 2025-05-13 · 0000950170-25-070285

As of 2024-03-31

46,628,000
Source

10-K · 2026-02-26 · 0001193125-26-073699

As of 2025-12-31

36,056,000
Source

10-K · 2025-03-05 · 0000950170-25-033510

As of 2024-12-31

41,870,000
Source

10-K · 2024-02-26 · 0000950170-24-020158

As of 2023-12-31

61,333,000
Source

10-K · 2023-02-28 · 0000950170-23-005067

As of 2022-12-31

Accounts Receivable, after Allowance for Credit Loss, CurrentUSD682,000
Source

10-Q · 2025-11-13 · 0001193125-25-279096

As of 2025-09-30

4,127,000
Source

10-Q · 2024-11-12 · 0000950170-24-125317

As of 2024-09-30

703,000
Source

10-Q · 2026-08-13 · 0001193125-26-347988

As of 2026-06-30

1,395,000
Source

10-Q · 2025-08-12 · 0000950170-25-107309

As of 2025-06-30

1,048,000
Source

10-Q · 2024-08-13 · 0000950170-24-096187

As of 2024-06-30

704,000
Source

10-Q · 2026-05-13 · 0001193125-26-220696

As of 2026-03-31

2,406,000
Source

10-Q · 2025-05-13 · 0000950170-25-070285

As of 2025-03-31

858,000
Source

10-Q · 2024-05-09 · 0000950170-24-056869

As of 2024-03-31

916,000
Source

10-K · 2026-02-26 · 0001193125-26-073699

As of 2025-12-31

3,539,000
Source

10-K · 2025-03-05 · 0000950170-25-033510

As of 2024-12-31

1,826,000
Source

10-K · 2024-02-26 · 0000950170-24-020158

As of 2023-12-31

38,480,000
Source

10-K · 2023-02-28 · 0000950170-23-005067

As of 2022-12-31

Assets, CurrentUSD221,251,000
Source

10-Q · 2025-11-13 · 0001193125-25-279096

As of 2025-09-30

310,294,000
Source

10-Q · 2024-11-12 · 0000950170-24-125317

As of 2024-09-30

157,953,000
Source

10-Q · 2026-08-13 · 0001193125-26-347988

As of 2026-06-30

230,397,000
Source

10-Q · 2025-08-12 · 0000950170-25-107309

As of 2025-06-30

319,388,000
Source

10-Q · 2024-08-13 · 0000950170-24-096187

As of 2024-06-30

179,526,000
Source

10-Q · 2026-05-13 · 0001193125-26-220696

As of 2026-03-31

248,217,000
Source

10-Q · 2025-05-13 · 0000950170-25-070285

As of 2025-03-31

394,375,000
Source

10-Q · 2024-05-09 · 0000950170-24-056869

As of 2024-03-31

208,704,000
Source

10-K · 2026-02-26 · 0001193125-26-073699

As of 2025-12-31

291,909,000
Source

10-K · 2025-03-05 · 0000950170-25-033510

As of 2024-12-31

331,540,000
Source

10-K · 2024-02-26 · 0000950170-24-020158

As of 2023-12-31

502,074,000
Source

10-K · 2023-02-28 · 0000950170-23-005067

As of 2022-12-31

Prepaid Expense and Other Assets, CurrentUSD5,146,000
Source

10-Q · 2025-11-13 · 0001193125-25-279096

As of 2025-09-30

9,244,000
Source

10-Q · 2024-11-12 · 0000950170-24-125317

As of 2024-09-30

3,480,000
Source

10-Q · 2026-08-13 · 0001193125-26-347988

As of 2026-06-30

6,172,000
Source

10-Q · 2025-08-12 · 0000950170-25-107309

As of 2025-06-30

13,461,000
Source

10-Q · 2024-08-13 · 0000950170-24-096187

As of 2024-06-30

4,000,000
Source

10-Q · 2026-05-13 · 0001193125-26-220696

As of 2026-03-31

5,386,000
Source

10-Q · 2025-05-13 · 0000950170-25-070285

As of 2025-03-31

9,973,000
Source

10-Q · 2024-05-09 · 0000950170-24-056869

As of 2024-03-31

4,131,000
Source

10-K · 2026-02-26 · 0001193125-26-073699

As of 2025-12-31

9,302,000
Source

10-K · 2025-03-05 · 0000950170-25-033510

As of 2024-12-31

14,539,000
Source

10-K · 2024-02-26 · 0000950170-24-020158

As of 2023-12-31

27,367,000
Source

10-K · 2023-02-28 · 0000950170-23-005067

As of 2022-12-31

Operating Lease, Right-of-Use AssetUSD42,413,000
Source

10-Q · 2025-11-13 · 0001193125-25-279096

As of 2025-09-30

58,441,000
Source

10-Q · 2024-11-12 · 0000950170-24-125317

As of 2024-09-30

40,554,000
Source

10-Q · 2026-08-13 · 0001193125-26-347988

As of 2026-06-30

43,814,000
Source

10-Q · 2025-08-12 · 0000950170-25-107309

As of 2025-06-30

59,547,000
Source

10-Q · 2024-08-13 · 0000950170-24-096187

As of 2024-06-30

41,078,000
Source

10-Q · 2026-05-13 · 0001193125-26-220696

As of 2026-03-31

45,178,000
Source

10-Q · 2025-05-13 · 0000950170-25-070285

As of 2025-03-31

60,620,000
Source

10-Q · 2024-05-09 · 0000950170-24-056869

As of 2024-03-31

41,609,000
Source

10-K · 2026-02-26 · 0001193125-26-073699

As of 2025-12-31

46,508,000
Source

10-K · 2025-03-05 · 0000950170-25-033510

As of 2024-12-31

61,675,000
Source

10-K · 2024-02-26 · 0000950170-24-020158

As of 2023-12-31

66,069,000
Source

10-K · 2023-02-28 · 0000950170-23-005067

As of 2022-12-31

Other Assets, NoncurrentUSD0
Source

10-Q · 2025-11-13 · 0001193125-25-279096

As of 2025-09-30

9,000
Source

10-Q · 2024-11-12 · 0000950170-24-125317

As of 2024-09-30

—0
Source

10-Q · 2025-08-12 · 0000950170-25-107309

As of 2025-06-30

9,000
Source

10-Q · 2024-08-13 · 0000950170-24-096187

As of 2024-06-30

—0
Source

10-Q · 2025-05-13 · 0000950170-25-070285

As of 2025-03-31

9,000
Source

10-Q · 2024-05-09 · 0000950170-24-056869

As of 2024-03-31

0
Source

10-K · 2026-02-26 · 0001193125-26-073699

As of 2025-12-31

9,000
Source

10-K · 2025-03-05 · 0000950170-25-033510

As of 2024-12-31

9,000
Source

10-K · 2024-02-26 · 0000950170-24-020158

As of 2023-12-31

33,000
Source

10-K · 2023-02-28 · 0000950170-23-005067

As of 2022-12-31

LIABILITIES AND EQUITY
Stockholders’ equity:
Preferred Stock, Value, IssuedUSD3,000
Source

10-Q · 2025-11-13 · 0001193125-25-279096

As of 2025-09-30

3,000
Source

10-Q · 2024-11-12 · 0000950170-24-125317

As of 2024-09-30

3,000
Source

10-Q · 2026-08-13 · 0001193125-26-347988

As of 2026-06-30

3,000
Source

10-Q · 2025-08-12 · 0000950170-25-107309

As of 2025-06-30

3,000
Source

10-Q · 2024-08-13 · 0000950170-24-096187

As of 2024-06-30

3,000
Source

10-Q · 2026-05-13 · 0001193125-26-220696

As of 2026-03-31

3,000
Source

10-Q · 2025-05-13 · 0000950170-25-070285

As of 2025-03-31

3,000
Source

10-Q · 2024-05-09 · 0000950170-24-056869

As of 2024-03-31

3,000
Source

10-K · 2026-02-26 · 0001193125-26-073699

As of 2025-12-31

3,000
Source

10-K · 2025-03-05 · 0000950170-25-033510

As of 2024-12-31

3,000
Source

10-K · 2024-02-26 · 0000950170-24-020158

As of 2023-12-31

3,000
Source

10-K · 2023-02-28 · 0000950170-23-005067

As of 2022-12-31

Common Stock, Value, IssuedUSD115,000
Source

10-Q · 2025-11-13 · 0001193125-25-279096

As of 2025-09-30

114,000
Source

10-Q · 2024-11-12 · 0000950170-24-125317

As of 2024-09-30

117,000
Source

10-Q · 2026-08-13 · 0001193125-26-347988

As of 2026-06-30

115,000
Source

10-Q · 2025-08-12 · 0000950170-25-107309

As of 2025-06-30

114,000
Source

10-Q · 2024-08-13 · 0000950170-24-096187

As of 2024-06-30

116,000
Source

10-Q · 2026-05-13 · 0001193125-26-220696

As of 2026-03-31

115,000
Source

10-Q · 2025-05-13 · 0000950170-25-070285

As of 2025-03-31

114,000
Source

10-Q · 2024-05-09 · 0000950170-24-056869

As of 2024-03-31

115,000
Source

10-K · 2026-02-26 · 0001193125-26-073699

As of 2025-12-31

114,000
Source

10-K · 2025-03-05 · 0000950170-25-033510

As of 2024-12-31

99,000
Source

10-K · 2024-02-26 · 0000950170-24-020158

As of 2023-12-31

97,000
Source

10-K · 2023-02-28 · 0000950170-23-005067

As of 2022-12-31

Additional Paid in CapitalUSD1,735,730,000
Source

10-Q · 2025-11-13 · 0001193125-25-279096

As of 2025-09-30

1,707,215,000
Source

10-Q · 2024-11-12 · 0000950170-24-125317

As of 2024-09-30

1,749,116,000
Source

10-Q · 2026-08-13 · 0001193125-26-347988

As of 2026-06-30

1,730,869,000
Source

10-Q · 2025-08-12 · 0000950170-25-107309

As of 2025-06-30

1,695,450,000
Source

10-Q · 2024-08-13 · 0000950170-24-096187

As of 2024-06-30

1,745,187,000
Source

10-Q · 2026-05-13 · 0001193125-26-220696

As of 2026-03-31

1,723,715,000
Source

10-Q · 2025-05-13 · 0000950170-25-070285

As of 2025-03-31

1,685,928,000
Source

10-Q · 2024-05-09 · 0000950170-24-056869

As of 2024-03-31

1,741,259,000
Source

10-K · 2026-02-26 · 0001193125-26-073699

As of 2025-12-31

1,716,335,000
Source

10-K · 2025-03-05 · 0000950170-25-033510

As of 2024-12-31

1,580,032,000
Source

10-K · 2024-02-26 · 0000950170-24-020158

As of 2023-12-31

1,536,497,000
Source

10-K · 2023-02-28 · 0000950170-23-005067

As of 2022-12-31

Retained Earnings (Accumulated Deficit)USD-1,501,935,000
Source

10-Q · 2025-11-13 · 0001193125-25-279096

As of 2025-09-30

-1,345,841,000
Source

10-Q · 2024-11-12 · 0000950170-24-125317

As of 2024-09-30

-1,595,681,000
Source

10-Q · 2026-08-13 · 0001193125-26-347988

As of 2026-06-30

-1,469,685,000
Source

10-Q · 2025-08-12 · 0000950170-25-107309

As of 2025-06-30

-1,298,163,000
Source

10-Q · 2024-08-13 · 0000950170-24-096187

As of 2024-06-30

-1,565,522,000
Source

10-Q · 2026-05-13 · 0001193125-26-220696

As of 2026-03-31

-1,435,615,000
Source

10-Q · 2025-05-13 · 0000950170-25-070285

As of 2025-03-31

-1,259,736,000
Source

10-Q · 2024-05-09 · 0000950170-24-056869

As of 2024-03-31

-1,534,309,000
Source

10-K · 2026-02-26 · 0001193125-26-073699

As of 2025-12-31

-1,397,994,000
Source

10-K · 2025-03-05 · 0000950170-25-033510

As of 2024-12-31

-1,211,732,000
Source

10-K · 2024-02-26 · 0000950170-24-020158

As of 2023-12-31

-1,050,804,000
Source

10-K · 2023-02-28 · 0000950170-23-005067

As of 2022-12-31

Accumulated Other Comprehensive Income (Loss), Net of TaxUSD153,000
Source

10-Q · 2025-11-13 · 0001193125-25-279096

As of 2025-09-30

835,000
Source

10-Q · 2024-11-12 · 0000950170-24-125317

As of 2024-09-30

-117,000
Source

10-Q · 2026-08-13 · 0001193125-26-347988

As of 2026-06-30

62,000
Source

10-Q · 2025-08-12 · 0000950170-25-107309

As of 2025-06-30

-422,000
Source

10-Q · 2024-08-13 · 0000950170-24-096187

As of 2024-06-30

-77,000
Source

10-Q · 2026-05-13 · 0001193125-26-220696

As of 2026-03-31

191,000
Source

10-Q · 2025-05-13 · 0000950170-25-070285

As of 2025-03-31

-194,000
Source

10-Q · 2024-05-09 · 0000950170-24-056869

As of 2024-03-31

116,000
Source

10-K · 2026-02-26 · 0001193125-26-073699

As of 2025-12-31

268,000
Source

10-K · 2025-03-05 · 0000950170-25-033510

As of 2024-12-31

15,000
Source

10-K · 2024-02-26 · 0000950170-24-020158

As of 2023-12-31

-1,854,000
Source

10-K · 2023-02-28 · 0000950170-23-005067

As of 2022-12-31

Stockholders' Equity Attributable to ParentUSD234,066,000
Source

10-Q · 2025-11-13 · 0001193125-25-279096

As of 2025-09-30

362,326,000
Source

10-Q · 2025-11-13 · 0001193125-25-279096

As of 2024-09-30

153,438,000
Source

10-Q · 2026-08-13 · 0001193125-26-347988

As of 2026-06-30

261,364,000
Source

10-Q · 2026-08-13 · 0001193125-26-347988

As of 2025-06-30

396,982,000
Source

10-Q · 2025-08-12 · 0000950170-25-107309

As of 2024-06-30

179,707,000
Source

10-Q · 2026-05-13 · 0001193125-26-220696

As of 2026-03-31

288,409,000
Source

10-Q · 2026-05-13 · 0001193125-26-220696

As of 2025-03-31

426,115,000
Source

10-Q · 2025-05-13 · 0000950170-25-070285

As of 2024-03-31

207,184,000
Source

10-K · 2026-02-26 · 0001193125-26-073699

As of 2025-12-31

318,726,000
Source

10-K · 2025-03-05 · 0000950170-25-033510

As of 2024-12-31

368,417,000
Source

10-K · 2024-02-26 · 0000950170-24-020158

As of 2023-12-31

483,939,000
Source

10-K · 2023-02-28 · 0000950170-23-005067

As of 2022-12-31

Liabilities and EquityUSD343,671,000
Source

10-Q · 2025-11-13 · 0001193125-25-279096

As of 2025-09-30

494,970,000
Source

10-Q · 2024-11-12 · 0000950170-24-125317

As of 2024-09-30

260,103,000
Source

10-Q · 2026-08-13 · 0001193125-26-347988

As of 2026-06-30

371,632,000
Source

10-Q · 2025-08-12 · 0000950170-25-107309

As of 2025-06-30

528,817,000
Source

10-Q · 2024-08-13 · 0000950170-24-096187

As of 2024-06-30

284,916,000
Source

10-Q · 2026-05-13 · 0001193125-26-220696

As of 2026-03-31

398,670,000
Source

10-Q · 2025-05-13 · 0000950170-25-070285

As of 2025-03-31

569,892,000
Source

10-Q · 2024-05-09 · 0000950170-24-056869

As of 2024-03-31

318,937,000
Source

10-K · 2026-02-26 · 0001193125-26-073699

As of 2025-12-31

440,694,000
Source

10-K · 2025-03-05 · 0000950170-25-033510

As of 2024-12-31

506,217,000
Source

10-K · 2024-02-26 · 0000950170-24-020158

As of 2023-12-31

705,561,000
Source

10-K · 2023-02-28 · 0000950170-23-005067

As of 2022-12-31

Current liabilities:
Liabilities, CurrentUSD28,111,000
Source

10-Q · 2025-11-13 · 0001193125-25-279096

As of 2025-09-30

37,422,000
Source

10-Q · 2024-11-12 · 0000950170-24-125317

As of 2024-09-30

32,592,000
Source

10-Q · 2026-08-13 · 0001193125-26-347988

As of 2026-06-30

28,673,000
Source

10-Q · 2025-08-12 · 0000950170-25-107309

As of 2025-06-30

34,793,000
Source

10-Q · 2024-08-13 · 0000950170-24-096187

As of 2024-06-30

30,689,000
Source

10-Q · 2026-05-13 · 0001193125-26-220696

As of 2026-03-31

28,159,000
Source

10-Q · 2025-05-13 · 0000950170-25-070285

As of 2025-03-31

45,369,000
Source

10-Q · 2024-05-09 · 0000950170-24-056869

As of 2024-03-31

36,071,000
Source

10-K · 2026-02-26 · 0001193125-26-073699

As of 2025-12-31

38,522,000
Source

10-K · 2025-03-05 · 0000950170-25-033510

As of 2024-12-31

39,094,000
Source

10-K · 2024-02-26 · 0000950170-24-020158

As of 2023-12-31

114,051,000
Source

10-K · 2023-02-28 · 0000950170-23-005067

As of 2022-12-31

Operating Lease, Liability, CurrentUSD4,751,000
Source

10-Q · 2025-11-13 · 0001193125-25-279096

As of 2025-09-30

6,893,000
Source

10-Q · 2024-11-12 · 0000950170-24-125317

As of 2024-09-30

4,922,000
Source

10-Q · 2026-08-13 · 0001193125-26-347988

As of 2026-06-30

5,656,000
Source

10-Q · 2025-08-12 · 0000950170-25-107309

As of 2025-06-30

6,644,000
Source

10-Q · 2024-08-13 · 0000950170-24-096187

As of 2024-06-30

4,740,000
Source

10-Q · 2026-05-13 · 0001193125-26-220696

As of 2026-03-31

6,544,000
Source

10-Q · 2025-05-13 · 0000950170-25-070285

As of 2025-03-31

6,402,000
Source

10-Q · 2024-05-09 · 0000950170-24-056869

As of 2024-03-31

4,562,000
Source

10-K · 2026-02-26 · 0001193125-26-073699

As of 2025-12-31

7,416,000
Source

10-K · 2025-03-05 · 0000950170-25-033510

As of 2024-12-31

6,176,000
Source

10-K · 2024-02-26 · 0000950170-24-020158

As of 2023-12-31

5,628,000
Source

10-K · 2023-02-28 · 0000950170-23-005067

As of 2022-12-31

Accounts Payable, CurrentUSD3,504,000
Source

10-Q · 2025-11-13 · 0001193125-25-279096

As of 2025-09-30

6,349,000
Source

10-Q · 2024-11-12 · 0000950170-24-125317

As of 2024-09-30

3,258,000
Source

10-Q · 2026-08-13 · 0001193125-26-347988

As of 2026-06-30

4,040,000
Source

10-Q · 2025-08-12 · 0000950170-25-107309

As of 2025-06-30

5,495,000
Source

10-Q · 2024-08-13 · 0000950170-24-096187

As of 2024-06-30

3,277,000
Source

10-Q · 2026-05-13 · 0001193125-26-220696

As of 2026-03-31

4,190,000
Source

10-Q · 2025-05-13 · 0000950170-25-070285

As of 2025-03-31

6,765,000
Source

10-Q · 2024-05-09 · 0000950170-24-056869

As of 2024-03-31

2,656,000
Source

10-K · 2026-02-26 · 0001193125-26-073699

As of 2025-12-31

9,365,000
Source

10-K · 2025-03-05 · 0000950170-25-033510

As of 2024-12-31

4,719,000
Source

10-K · 2024-02-26 · 0000950170-24-020158

As of 2023-12-31

8,265,000
Source

10-K · 2023-02-28 · 0000950170-23-005067

As of 2022-12-31

Operating Lease, Liability, NoncurrentUSD74,494,000
Source

10-Q · 2025-11-13 · 0001193125-25-279096

As of 2025-09-30

92,085,000
Source

10-Q · 2024-11-12 · 0000950170-24-125317

As of 2024-09-30

70,753,000
Source

10-Q · 2026-08-13 · 0001193125-26-347988

As of 2026-06-30

75,675,000
Source

10-Q · 2025-08-12 · 0000950170-25-107309

As of 2025-06-30

93,918,000
Source

10-Q · 2024-08-13 · 0000950170-24-096187

As of 2024-06-30

72,045,000
Source

10-Q · 2026-05-13 · 0001193125-26-220696

As of 2026-03-31

76,785,000
Source

10-Q · 2025-05-13 · 0000950170-25-070285

As of 2025-03-31

95,668,000
Source

10-Q · 2024-05-09 · 0000950170-24-056869

As of 2024-03-31

73,287,000
Source

10-K · 2026-02-26 · 0001193125-26-073699

As of 2025-12-31

77,849,000
Source

10-K · 2025-03-05 · 0000950170-25-033510

As of 2024-12-31

97,360,000
Source

10-K · 2024-02-26 · 0000950170-24-020158

As of 2023-12-31

103,710,000
Source

10-K · 2023-02-28 · 0000950170-23-005067

As of 2022-12-31

Additional Financial Items
Accrued Liabilities, CurrentUSD17,571,000
Source

10-Q · 2025-11-13 · 0001193125-25-279096

As of 2025-09-30

23,580,000
Source

10-Q · 2024-11-12 · 0000950170-24-125317

As of 2024-09-30

14,904,000
Source

10-Q · 2026-08-13 · 0001193125-26-347988

As of 2026-06-30

18,182,000
Source

10-Q · 2025-08-12 · 0000950170-25-107309

As of 2025-06-30

22,654,000
Source

10-Q · 2024-08-13 · 0000950170-24-096187

As of 2024-06-30

13,642,000
Source

10-Q · 2026-05-13 · 0001193125-26-220696

As of 2026-03-31

17,213,000
Source

10-Q · 2025-05-13 · 0000950170-25-070285

As of 2025-03-31

32,043,000
Source

10-Q · 2024-05-09 · 0000950170-24-056869

As of 2024-03-31

20,024,000
Source

10-K · 2026-02-26 · 0001193125-26-073699

As of 2025-12-31

21,348,000
Source

10-K · 2025-03-05 · 0000950170-25-033510

As of 2024-12-31

27,514,000
Source

10-K · 2024-02-26 · 0000950170-24-020158

As of 2023-12-31

53,932,000
Source

10-K · 2023-02-28 · 0000950170-23-005067

As of 2022-12-31

Deferred Tax Liabilities, NetUSD————————387,974,000
Source

10-K · 2026-02-26 · 0001193125-26-073699

As of 2025-12-31

362,084,000
Source

10-K · 2025-03-05 · 0000950170-25-033510

As of 2024-12-31

323,962,000
Source

10-K · 2024-02-26 · 0000950170-24-020158

As of 2023-12-31

296,247,000
Source

10-K · 2023-02-28 · 0000950170-23-005067

As of 2022-12-31

Short-term InvestmentsUSD174,801,000
Source

10-Q · 2025-11-13 · 0001193125-25-279096

As of 2025-09-30

259,014,000
Source

10-Q · 2024-11-12 · 0000950170-24-125317

As of 2024-09-30

121,341,000
Source

10-Q · 2026-08-13 · 0001193125-26-347988

As of 2026-06-30

181,581,000
Source

10-Q · 2025-08-12 · 0000950170-25-107309

As of 2025-06-30

267,962,000
Source

10-Q · 2024-08-13 · 0000950170-24-096187

As of 2024-06-30

135,252,000
Source

10-Q · 2026-05-13 · 0001193125-26-220696

As of 2026-03-31

195,505,000
Source

10-Q · 2025-05-13 · 0000950170-25-070285

As of 2025-03-31

—157,029,000
Source

10-K · 2026-02-26 · 0001193125-26-073699

As of 2025-12-31

243,012,000
Source

10-K · 2025-03-05 · 0000950170-25-033510

As of 2024-12-31

273,305,000
Source

10-K · 2024-02-26 · 0000950170-24-020158

As of 2023-12-31

374,894,000
Source

10-K · 2023-02-28 · 0000950170-23-005067

As of 2022-12-31

Cash, Cash Equivalents, and Short-term Investments———
Source

10-Q · 2026-08-13 · 0001193125-26-347988

As of 2026-06-30

———
Source

10-Q · 2026-05-13 · 0001193125-26-220696

As of 2026-03-31

——————

Lines labelled “Derived” are calculated from reported figures.

cash flow · annual statements
Line itemQ4 2025Q4 2024Q3 2025Q3 2024Q2 2026Q2 2025Q1 2026Q1 2025FY 2025FY 2024FY 2023FY 2022
Cash flows from operating activities:
Net Income (Loss), Including Portion Attributable to Noncontrolling InterestUSD——————-31,213,000
Source

10-Q · 2026-05-13 · 0001193125-26-220696

2026-01-01 to 2026-03-31

-37,621,000
Source

10-Q · 2026-05-13 · 0001193125-26-220696

2025-01-01 to 2025-03-31

-136,315,000
Source

10-K · 2026-02-26 · 0001193125-26-073699

2025-01-01 to 2025-12-31

-186,262,000
Source

10-K · 2025-03-05 · 0000950170-25-033510

2024-01-01 to 2024-12-31

-160,928,000
Source

10-K · 2024-02-26 · 0000950170-24-020158

2023-01-01 to 2023-12-31

-281,721,000
Source

10-K · 2023-02-28 · 0000950170-23-005067

2022-01-01 to 2022-12-31

Adjustments to reconcile net income to net cash provided by operating activities:
Depreciation, Depletion and AmortizationUSD——————2,918,000
Source

10-Q · 2026-05-13 · 0001193125-26-220696

2026-01-01 to 2026-03-31

3,333,000
Source

10-Q · 2026-05-13 · 0001193125-26-220696

2025-01-01 to 2025-03-31

12,901,000
Source

10-K · 2026-02-26 · 0001193125-26-073699

2025-01-01 to 2025-12-31

18,962,000
Source

10-K · 2025-03-05 · 0000950170-25-033510

2024-01-01 to 2024-12-31

18,282,000
Source

10-K · 2024-02-26 · 0000950170-24-020158

2023-01-01 to 2023-12-31

13,758,000
Source

10-K · 2023-02-28 · 0000950170-23-005067

2022-01-01 to 2022-12-31

Changes in operating assets and liabilities:
Increase (Decrease) in Accounts ReceivableUSD——————-212,000
Source

10-Q · 2026-05-13 · 0001193125-26-220696

2026-01-01 to 2026-03-31

-1,134,000
Source

10-Q · 2026-05-13 · 0001193125-26-220696

2025-01-01 to 2025-03-31

-2,624,000
Source

10-K · 2026-02-26 · 0001193125-26-073699

2025-01-01 to 2025-12-31

1,113,000
Source

10-K · 2025-03-05 · 0000950170-25-033510

2024-01-01 to 2024-12-31

-36,654,000
Source

10-K · 2024-02-26 · 0000950170-24-020158

2023-01-01 to 2023-12-31

29,804,000
Source

10-K · 2023-02-28 · 0000950170-23-005067

2022-01-01 to 2022-12-31

Net Cash Provided by (Used in) Operating ActivitiesUSD————-23,400,000
Source

10-Q · 2026-08-13 · 0001193125-26-347988

2026-04-01 to 2026-06-30

—-30,822,000
Source

10-Q · 2026-05-13 · 0001193125-26-220696

2026-01-01 to 2026-03-31

-33,809,000
Source

10-Q · 2026-05-13 · 0001193125-26-220696

2025-01-01 to 2025-03-31

-106,084,000
Source

10-K · 2026-02-26 · 0001193125-26-073699

2025-01-01 to 2025-12-31

-122,874,000
Source

10-K · 2025-03-05 · 0000950170-25-033510

2024-01-01 to 2024-12-31

-132,263,000
Source

10-K · 2024-02-26 · 0000950170-24-020158

2023-01-01 to 2023-12-31

-248,208,000
Source

10-K · 2023-02-28 · 0000950170-23-005067

2022-01-01 to 2022-12-31

Cash flows from investing activities:
Net Cash Provided by (Used in) Investing ActivitiesUSD——————23,587,000
Source

10-Q · 2026-05-13 · 0001193125-26-220696

2026-01-01 to 2026-03-31

42,673,000
Source

10-Q · 2026-05-13 · 0001193125-26-220696

2025-01-01 to 2025-03-31

111,166,000
Source

10-K · 2026-02-26 · 0001193125-26-073699

2025-01-01 to 2025-12-31

12,218,000
Source

10-K · 2025-03-05 · 0000950170-25-033510

2024-01-01 to 2024-12-31

112,665,000
Source

10-K · 2024-02-26 · 0000950170-24-020158

2023-01-01 to 2023-12-31

166,751,000
Source

10-K · 2023-02-28 · 0000950170-23-005067

2022-01-01 to 2022-12-31

Payments to Acquire Property, Plant, and EquipmentUSD——————239,000
Source

10-Q · 2026-05-13 · 0001193125-26-220696

2026-01-01 to 2026-03-31

1,196,000
Source

10-Q · 2026-05-13 · 0001193125-26-220696

2025-01-01 to 2025-03-31

5,953,000
Source

10-K · 2026-02-26 · 0001193125-26-073699

2025-01-01 to 2025-12-31

730,000
Source

10-K · 2025-03-05 · 0000950170-25-033510

2024-01-01 to 2024-12-31

6,153,000
Source

10-K · 2024-02-26 · 0000950170-24-020158

2023-01-01 to 2023-12-31

35,566,000
Source

10-K · 2023-02-28 · 0000950170-23-005067

2022-01-01 to 2022-12-31

Cash flows from financing activities:
Net Cash Provided by (Used in) Financing ActivitiesUSD———————0
Source

10-Q · 2025-05-13 · 0000950170-25-070285

2025-01-01 to 2025-03-31

5,490,000
Source

10-K · 2026-02-26 · 0001193125-26-073699

2025-01-01 to 2025-12-31

99,892,000
Source

10-K · 2025-03-05 · 0000950170-25-033510

2024-01-01 to 2024-12-31

85,000
Source

10-K · 2024-02-26 · 0000950170-24-020158

2023-01-01 to 2023-12-31

9,207,000
Source

10-K · 2023-02-28 · 0000950170-23-005067

2022-01-01 to 2022-12-31

Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate EffectUSD——————-7,235,000
Source

10-Q · 2026-05-13 · 0001193125-26-220696

2026-01-01 to 2026-03-31

8,864,000
Source

10-Q · 2026-05-13 · 0001193125-26-220696

2025-01-01 to 2025-03-31

10,572,000
Source

10-K · 2026-02-26 · 0001193125-26-073699

2025-01-01 to 2025-12-31

-10,764,000
Source

10-K · 2025-03-05 · 0000950170-25-033510

2024-01-01 to 2024-12-31

-19,513,000
Source

10-K · 2024-02-26 · 0000950170-24-020158

2023-01-01 to 2023-12-31

-72,250,000
Source

10-K · 2023-02-28 · 0000950170-23-005067

2022-01-01 to 2022-12-31

Supplemental disclosure of cash flow information:
Income Taxes Paid, NetUSD————————1,600
Source

10-K · 2026-02-26 · 0001193125-26-073699

2025-01-01 to 2025-12-31

———
Additional Financial Items
Share-based Payment Arrangement, ExpenseUSD——4,861,000
Source

10-Q · 2025-11-13 · 0001193125-25-279096

2025-07-01 to 2025-09-30

11,765,000
Source

10-Q · 2025-11-13 · 0001193125-25-279096

2024-07-01 to 2024-09-30

3,518,000
Source

10-Q · 2026-08-13 · 0001193125-26-347988

2026-04-01 to 2026-06-30

7,154,000
Source

10-Q · 2026-08-13 · 0001193125-26-347988

2025-04-01 to 2025-06-30

3,929,000
Source

10-Q · 2026-05-13 · 0001193125-26-220696

2026-01-01 to 2026-03-31

7,381,000
Source

10-Q · 2026-05-13 · 0001193125-26-220696

2025-01-01 to 2025-03-31

24,924,000
Source

10-K · 2026-02-26 · 0001193125-26-073699

2025-01-01 to 2025-12-31

41,496,000
Source

10-K · 2025-03-05 · 0000950170-25-033510

2024-01-01 to 2024-12-31

43,459,000
Source

10-K · 2024-02-26 · 0000950170-24-020158

2023-01-01 to 2023-12-31

78,733,000
Source

10-K · 2023-02-28 · 0000950170-23-005067

2022-01-01 to 2022-12-31

Debt Securities, Available-for-sale, Realized Gain (Loss)USD————————0
Source

10-K · 2026-02-26 · 0001193125-26-073699

2025-01-01 to 2025-12-31

0
Source

10-K · 2025-03-05 · 0000950170-25-033510

2024-01-01 to 2024-12-31

0
Source

10-K · 2024-02-26 · 0000950170-24-020158

2023-01-01 to 2023-12-31

0
Source

10-K · 2023-02-28 · 0000950170-23-005067

2022-01-01 to 2022-12-31

Gain (Loss) on Disposition of Property Plant EquipmentUSD————————-9,000
Source

10-K · 2026-02-26 · 0001193125-26-073699

2025-01-01 to 2025-12-31

-942,000
Source

10-K · 2025-03-05 · 0000950170-25-033510

2024-01-01 to 2024-12-31

——
General and Administrative ExpenseUSD——10,638,000
Source

10-Q · 2025-11-13 · 0001193125-25-279096

2025-07-01 to 2025-09-30

20,801,000
Source

10-Q · 2025-11-13 · 0001193125-25-279096

2024-07-01 to 2024-09-30

8,829,000
Source

10-Q · 2026-08-13 · 0001193125-26-347988

2026-04-01 to 2026-06-30

11,445,000
Source

10-Q · 2026-08-13 · 0001193125-26-347988

2025-04-01 to 2025-06-30

9,596,000
Source

10-Q · 2026-05-13 · 0001193125-26-220696

2026-01-01 to 2026-03-31

13,773,000
Source

10-Q · 2026-05-13 · 0001193125-26-220696

2025-01-01 to 2025-03-31

46,521,000
Source

10-K · 2026-02-26 · 0001193125-26-073699

2025-01-01 to 2025-12-31

74,169,000
Source

10-K · 2025-03-05 · 0000950170-25-033510

2024-01-01 to 2024-12-31

81,448,000
Source

10-K · 2024-02-26 · 0000950170-24-020158

2023-01-01 to 2023-12-31

84,232,000
Source

10-K · 2023-02-28 · 0000950170-23-005067

2022-01-01 to 2022-12-31

Income Tax Expense (Benefit)USD————————2,000
Source

10-K · 2026-02-26 · 0001193125-26-073699

2025-01-01 to 2025-12-31

0
Source

10-K · 2025-03-05 · 0000950170-25-033510

2024-01-01 to 2024-12-31

0
Source

10-K · 2024-02-26 · 0000950170-24-020158

2023-01-01 to 2023-12-31

0
Source

10-K · 2023-02-28 · 0000950170-23-005067

2022-01-01 to 2022-12-31

Investment Income, InterestUSD——2,575,000
Source

10-Q · 2025-11-13 · 0001193125-25-279096

2025-07-01 to 2025-09-30

4,438,000
Source

10-Q · 2025-11-13 · 0001193125-25-279096

2024-07-01 to 2024-09-30

1,555,000
Source

10-Q · 2026-08-13 · 0001193125-26-347988

2026-04-01 to 2026-06-30

2,921,000
Source

10-Q · 2026-08-13 · 0001193125-26-347988

2025-04-01 to 2025-06-30

1,867,000
Source

10-Q · 2026-05-13 · 0001193125-26-220696

2026-01-01 to 2026-03-31

3,336,000
Source

10-Q · 2026-05-13 · 0001193125-26-220696

2025-01-01 to 2025-03-31

11,052,000
Source

10-K · 2026-02-26 · 0001193125-26-073699

2025-01-01 to 2025-12-31

17,288,000
Source

10-K · 2025-03-05 · 0000950170-25-033510

2024-01-01 to 2024-12-31

17,186,000
Source

10-K · 2024-02-26 · 0000950170-24-020158

2023-01-01 to 2023-12-31

5,842,000
Source

10-K · 2023-02-28 · 0000950170-23-005067

2022-01-01 to 2022-12-31

Net Income (Loss) Attributable to ParentUSD——-32,250,000
Source

10-Q · 2025-11-13 · 0001193125-25-279096

2025-07-01 to 2025-09-30

-47,678,000
Source

10-Q · 2025-11-13 · 0001193125-25-279096

2024-07-01 to 2024-09-30

-30,159,000
Source

10-Q · 2026-08-13 · 0001193125-26-347988

2026-04-01 to 2026-06-30

-34,070,000
Source

10-Q · 2026-08-13 · 0001193125-26-347988

2025-04-01 to 2025-06-30

-31,213,000
Source

10-Q · 2026-05-13 · 0001193125-26-220696

2026-01-01 to 2026-03-31

-37,621,000
Source

10-Q · 2026-05-13 · 0001193125-26-220696

2025-01-01 to 2025-03-31

-136,315,000
Source

10-K · 2026-02-26 · 0001193125-26-073699

2025-01-01 to 2025-12-31

-186,262,000
Source

10-K · 2025-03-05 · 0000950170-25-033510

2024-01-01 to 2024-12-31

-160,928,000
Source

10-K · 2024-02-26 · 0000950170-24-020158

2023-01-01 to 2023-12-31

-281,721,000
Source

10-K · 2023-02-28 · 0000950170-23-005067

2022-01-01 to 2022-12-31

Operating ExpensesUSD——36,476,000
Source

10-Q · 2025-11-13 · 0001193125-25-279096

2025-07-01 to 2025-09-30

55,451,000
Source

10-Q · 2025-11-13 · 0001193125-25-279096

2024-07-01 to 2024-09-30

33,216,000
Source

10-Q · 2026-08-13 · 0001193125-26-347988

2026-04-01 to 2026-06-30

38,875,000
Source

10-Q · 2026-08-13 · 0001193125-26-347988

2025-04-01 to 2025-06-30

34,299,000
Source

10-Q · 2026-05-13 · 0001193125-26-220696

2026-01-01 to 2026-03-31

42,909,000
Source

10-Q · 2026-05-13 · 0001193125-26-220696

2025-01-01 to 2025-03-31

154,350,000
Source

10-K · 2026-02-26 · 0001193125-26-073699

2025-01-01 to 2025-12-31

223,907,000
Source

10-K · 2025-03-05 · 0000950170-25-033510

2024-01-01 to 2024-12-31

254,044,000
Source

10-K · 2024-02-26 · 0000950170-24-020158

2023-01-01 to 2023-12-31

404,686,000
Source

10-K · 2023-02-28 · 0000950170-23-005067

2022-01-01 to 2022-12-31

Other Nonoperating Income (Expense)USD——2,485,000
Source

10-Q · 2025-11-13 · 0001193125-25-279096

2025-07-01 to 2025-09-30

4,699,000
Source

10-Q · 2025-11-13 · 0001193125-25-279096

2024-07-01 to 2024-09-30

975,000
Source

10-Q · 2026-08-13 · 0001193125-26-347988

2026-04-01 to 2026-06-30

2,898,000
Source

10-Q · 2026-08-13 · 0001193125-26-347988

2025-04-01 to 2025-06-30

1,787,000
Source

10-Q · 2026-05-13 · 0001193125-26-220696

2026-01-01 to 2026-03-31

3,659,000
Source

10-Q · 2026-05-13 · 0001193125-26-220696

2025-01-01 to 2025-03-31

11,389,000
Source

10-K · 2026-02-26 · 0001193125-26-073699

2025-01-01 to 2025-12-31

24,014,000
Source

10-K · 2025-03-05 · 0000950170-25-033510

2024-01-01 to 2024-12-31

29,583,000
Source

10-K · 2024-02-26 · 0000950170-24-020158

2023-01-01 to 2023-12-31

26,665,000
Source

10-K · 2023-02-28 · 0000950170-23-005067

2022-01-01 to 2022-12-31

Payments to Acquire InvestmentsUSD——————28,729,000
Source

10-Q · 2026-05-13 · 0001193125-26-220696

2026-01-01 to 2026-03-31

48,624,000
Source

10-Q · 2026-05-13 · 0001193125-26-220696

2025-01-01 to 2025-03-31

195,143,000
Source

10-K · 2026-02-26 · 0001193125-26-073699

2025-01-01 to 2025-12-31

317,750,000
Source

10-K · 2025-03-05 · 0000950170-25-033510

2024-01-01 to 2024-12-31

358,810,000
Source

10-K · 2024-02-26 · 0000950170-24-020158

2023-01-01 to 2023-12-31

404,796,000
Source

10-K · 2023-02-28 · 0000950170-23-005067

2022-01-01 to 2022-12-31

Proceeds from Stock Options ExercisedUSD———————0
Source

10-Q · 2025-05-13 · 0000950170-25-070285

2025-01-01 to 2025-03-31

0
Source

10-K · 2026-02-26 · 0001193125-26-073699

2025-01-01 to 2025-12-31

295,000
Source

10-K · 2025-03-05 · 0000950170-25-033510

2024-01-01 to 2024-12-31

85,000
Source

10-K · 2024-02-26 · 0000950170-24-020158

2023-01-01 to 2023-12-31

9,207,000
Source

10-K · 2023-02-28 · 0000950170-23-005067

2022-01-01 to 2022-12-31

Cash, Cash Equivalents, and Short-term Investments—————
Source

10-Q · 2026-08-13 · 0001193125-26-347988

As of 2026-06-30

——
Source

10-Q · 2026-05-13 · 0001193125-26-220696

As of 2026-03-31

—————

Lines labelled “Derived” are calculated from reported figures.

income statement · annual statements
Line itemQ4 2025Q4 2024Q3 2025Q3 2024Q2 2026Q2 2025Q1 2026Q1 2025FY 2025FY 2024FY 2023FY 2022
Total RevenueUSD——1,741,000
Source

10-Q · 2025-11-13 · 0001193125-25-279096

2025-07-01 to 2025-09-30

3,074,000
Source

10-Q · 2025-11-13 · 0001193125-25-279096

2024-07-01 to 2024-09-30

2,082,000
Source

10-Q · 2026-08-13 · 0001193125-26-347988

2026-04-01 to 2026-06-30

1,907,000
Source

10-Q · 2026-08-13 · 0001193125-26-347988

2025-04-01 to 2025-06-30

1,299,000
Source

10-Q · 2026-05-13 · 0001193125-26-220696

2026-01-01 to 2026-03-31

1,629,000
Source

10-Q · 2026-05-13 · 0001193125-26-220696

2025-01-01 to 2025-03-31

6,646,000
Source

10-K · 2026-02-26 · 0001193125-26-073699

2025-01-01 to 2025-12-31

13,631,000
Source

10-K · 2025-03-05 · 0000950170-25-033510

2024-01-01 to 2024-12-31

63,533,000
Source

10-K · 2024-02-26 · 0000950170-24-020158

2023-01-01 to 2023-12-31

96,300,000
Source

10-K · 2023-02-28 · 0000950170-23-005067

2022-01-01 to 2022-12-31

Operating Income (Loss)USD——-34,735,000
Source

10-Q · 2025-11-13 · 0001193125-25-279096

2025-07-01 to 2025-09-30

-52,377,000
Source

10-Q · 2025-11-13 · 0001193125-25-279096

2024-07-01 to 2024-09-30

-31,134,000
Source

10-Q · 2026-08-13 · 0001193125-26-347988

2026-04-01 to 2026-06-30

-36,968,000
Source

10-Q · 2026-08-13 · 0001193125-26-347988

2025-04-01 to 2025-06-30

-33,000,000
Source

10-Q · 2026-05-13 · 0001193125-26-220696

2026-01-01 to 2026-03-31

-41,280,000
Source

10-Q · 2026-05-13 · 0001193125-26-220696

2025-01-01 to 2025-03-31

-147,704,000
Source

10-K · 2026-02-26 · 0001193125-26-073699

2025-01-01 to 2025-12-31

-210,276,000
Source

10-K · 2025-03-05 · 0000950170-25-033510

2024-01-01 to 2024-12-31

-190,511,000
Source

10-K · 2024-02-26 · 0000950170-24-020158

2023-01-01 to 2023-12-31

-308,386,000
Source

10-K · 2023-02-28 · 0000950170-23-005067

2022-01-01 to 2022-12-31

Other Nonoperating Income (Expense)USD——2,485,000
Source

10-Q · 2025-11-13 · 0001193125-25-279096

2025-07-01 to 2025-09-30

4,699,000
Source

10-Q · 2025-11-13 · 0001193125-25-279096

2024-07-01 to 2024-09-30

975,000
Source

10-Q · 2026-08-13 · 0001193125-26-347988

2026-04-01 to 2026-06-30

2,898,000
Source

10-Q · 2026-08-13 · 0001193125-26-347988

2025-04-01 to 2025-06-30

1,787,000
Source

10-Q · 2026-05-13 · 0001193125-26-220696

2026-01-01 to 2026-03-31

3,659,000
Source

10-Q · 2026-05-13 · 0001193125-26-220696

2025-01-01 to 2025-03-31

11,389,000
Source

10-K · 2026-02-26 · 0001193125-26-073699

2025-01-01 to 2025-12-31

24,014,000
Source

10-K · 2025-03-05 · 0000950170-25-033510

2024-01-01 to 2024-12-31

29,583,000
Source

10-K · 2024-02-26 · 0000950170-24-020158

2023-01-01 to 2023-12-31

26,665,000
Source

10-K · 2023-02-28 · 0000950170-23-005067

2022-01-01 to 2022-12-31

Income Tax Expense (Benefit)USD————————2,000
Source

10-K · 2026-02-26 · 0001193125-26-073699

2025-01-01 to 2025-12-31

0
Source

10-K · 2025-03-05 · 0000950170-25-033510

2024-01-01 to 2024-12-31

0
Source

10-K · 2024-02-26 · 0000950170-24-020158

2023-01-01 to 2023-12-31

0
Source

10-K · 2023-02-28 · 0000950170-23-005067

2022-01-01 to 2022-12-31

Net Income (Loss) Attributable to ParentUSD——-32,250,000
Source

10-Q · 2025-11-13 · 0001193125-25-279096

2025-07-01 to 2025-09-30

-47,678,000
Source

10-Q · 2025-11-13 · 0001193125-25-279096

2024-07-01 to 2024-09-30

-30,159,000
Source

10-Q · 2026-08-13 · 0001193125-26-347988

2026-04-01 to 2026-06-30

-34,070,000
Source

10-Q · 2026-08-13 · 0001193125-26-347988

2025-04-01 to 2025-06-30

-31,213,000
Source

10-Q · 2026-05-13 · 0001193125-26-220696

2026-01-01 to 2026-03-31

-37,621,000
Source

10-Q · 2026-05-13 · 0001193125-26-220696

2025-01-01 to 2025-03-31

-136,315,000
Source

10-K · 2026-02-26 · 0001193125-26-073699

2025-01-01 to 2025-12-31

-186,262,000
Source

10-K · 2025-03-05 · 0000950170-25-033510

2024-01-01 to 2024-12-31

-160,928,000
Source

10-K · 2024-02-26 · 0000950170-24-020158

2023-01-01 to 2023-12-31

-281,721,000
Source

10-K · 2023-02-28 · 0000950170-23-005067

2022-01-01 to 2022-12-31

Earnings Per Share, BasicUSD per share——-0.27
Source

10-Q · 2025-11-13 · 0001193125-25-279096

2025-07-01 to 2025-09-30

-0.4
Source

10-Q · 2025-11-13 · 0001193125-25-279096

2024-07-01 to 2024-09-30

-0.25
Source

10-Q · 2026-08-13 · 0001193125-26-347988

2026-04-01 to 2026-06-30

-0.29
Source

10-Q · 2026-08-13 · 0001193125-26-347988

2025-04-01 to 2025-06-30

-0.26
Source

10-Q · 2026-05-13 · 0001193125-26-220696

2026-01-01 to 2026-03-31

-0.32
Source

10-Q · 2026-05-13 · 0001193125-26-220696

2025-01-01 to 2025-03-31

-1.15
Source

10-K · 2026-02-26 · 0001193125-26-073699

2025-01-01 to 2025-12-31

-1.64
Source

10-K · 2025-03-05 · 0000950170-25-033510

2024-01-01 to 2024-12-31

-1.64
Source

10-K · 2024-02-26 · 0000950170-24-020158

2023-01-01 to 2023-12-31

-2.91
Source

10-K · 2023-02-28 · 0000950170-23-005067

2022-01-01 to 2022-12-31

Earnings Per Share, DilutedUSD per share——-0.27
Source

10-Q · 2025-11-13 · 0001193125-25-279096

2025-07-01 to 2025-09-30

-0.4
Source

10-Q · 2025-11-13 · 0001193125-25-279096

2024-07-01 to 2024-09-30

-0.25
Source

10-Q · 2026-08-13 · 0001193125-26-347988

2026-04-01 to 2026-06-30

-0.29
Source

10-Q · 2026-08-13 · 0001193125-26-347988

2025-04-01 to 2025-06-30

-0.26
Source

10-Q · 2026-05-13 · 0001193125-26-220696

2026-01-01 to 2026-03-31

-0.32
Source

10-Q · 2026-05-13 · 0001193125-26-220696

2025-01-01 to 2025-03-31

-1.15
Source

10-K · 2026-02-26 · 0001193125-26-073699

2025-01-01 to 2025-12-31

-1.64
Source

10-K · 2025-03-05 · 0000950170-25-033510

2024-01-01 to 2024-12-31

-1.64
Source

10-K · 2024-02-26 · 0000950170-24-020158

2023-01-01 to 2023-12-31

-2.91
Source

10-K · 2023-02-28 · 0000950170-23-005067

2022-01-01 to 2022-12-31

Weighted Average Number of Shares Outstanding, Basicshares——118,998,693
Source

10-Q · 2025-11-13 · 0001193125-25-279096

2025-07-01 to 2025-09-30

117,769,161
Source

10-Q · 2025-11-13 · 0001193125-25-279096

2024-07-01 to 2024-09-30

120,397,390
Source

10-Q · 2026-08-13 · 0001193125-26-347988

2026-04-01 to 2026-06-30

118,528,046
Source

10-Q · 2026-08-13 · 0001193125-26-347988

2025-04-01 to 2025-06-30

120,030,638
Source

10-Q · 2026-05-13 · 0001193125-26-220696

2026-01-01 to 2026-03-31

118,375,540
Source

10-Q · 2026-05-13 · 0001193125-26-220696

2025-01-01 to 2025-03-31

118,789,974
Source

10-K · 2026-02-26 · 0001193125-26-073699

2025-01-01 to 2025-12-31

113,685,177
Source

10-K · 2025-03-05 · 0000950170-25-033510

2024-01-01 to 2024-12-31

98,411,162
Source

10-K · 2024-02-26 · 0000950170-24-020158

2023-01-01 to 2023-12-31

96,826,058
Source

10-K · 2023-02-28 · 0000950170-23-005067

2022-01-01 to 2022-12-31

Weighted Average Number of Shares Outstanding, Dilutedshares——118,998,693
Source

10-Q · 2025-11-13 · 0001193125-25-279096

2025-07-01 to 2025-09-30

117,769,161
Source

10-Q · 2025-11-13 · 0001193125-25-279096

2024-07-01 to 2024-09-30

120,397,390
Source

10-Q · 2026-08-13 · 0001193125-26-347988

2026-04-01 to 2026-06-30

118,528,046
Source

10-Q · 2026-08-13 · 0001193125-26-347988

2025-04-01 to 2025-06-30

120,030,638
Source

10-Q · 2026-05-13 · 0001193125-26-220696

2026-01-01 to 2026-03-31

118,375,540
Source

10-Q · 2026-05-13 · 0001193125-26-220696

2025-01-01 to 2025-03-31

118,789,974
Source

10-K · 2026-02-26 · 0001193125-26-073699

2025-01-01 to 2025-12-31

113,685,177
Source

10-K · 2025-03-05 · 0000950170-25-033510

2024-01-01 to 2024-12-31

98,411,162
Source

10-K · 2024-02-26 · 0000950170-24-020158

2023-01-01 to 2023-12-31

96,826,058
Source

10-K · 2023-02-28 · 0000950170-23-005067

2022-01-01 to 2022-12-31

Additional Financial Items
General and Administrative ExpenseUSD——10,638,000
Source

10-Q · 2025-11-13 · 0001193125-25-279096

2025-07-01 to 2025-09-30

20,801,000
Source

10-Q · 2025-11-13 · 0001193125-25-279096

2024-07-01 to 2024-09-30

8,829,000
Source

10-Q · 2026-08-13 · 0001193125-26-347988

2026-04-01 to 2026-06-30

11,445,000
Source

10-Q · 2026-08-13 · 0001193125-26-347988

2025-04-01 to 2025-06-30

9,596,000
Source

10-Q · 2026-05-13 · 0001193125-26-220696

2026-01-01 to 2026-03-31

13,773,000
Source

10-Q · 2026-05-13 · 0001193125-26-220696

2025-01-01 to 2025-03-31

46,521,000
Source

10-K · 2026-02-26 · 0001193125-26-073699

2025-01-01 to 2025-12-31

74,169,000
Source

10-K · 2025-03-05 · 0000950170-25-033510

2024-01-01 to 2024-12-31

81,448,000
Source

10-K · 2024-02-26 · 0000950170-24-020158

2023-01-01 to 2023-12-31

84,232,000
Source

10-K · 2023-02-28 · 0000950170-23-005067

2022-01-01 to 2022-12-31

Investment Income, InterestUSD——2,575,000
Source

10-Q · 2025-11-13 · 0001193125-25-279096

2025-07-01 to 2025-09-30

4,438,000
Source

10-Q · 2025-11-13 · 0001193125-25-279096

2024-07-01 to 2024-09-30

1,555,000
Source

10-Q · 2026-08-13 · 0001193125-26-347988

2026-04-01 to 2026-06-30

2,921,000
Source

10-Q · 2026-08-13 · 0001193125-26-347988

2025-04-01 to 2025-06-30

1,867,000
Source

10-Q · 2026-05-13 · 0001193125-26-220696

2026-01-01 to 2026-03-31

3,336,000
Source

10-Q · 2026-05-13 · 0001193125-26-220696

2025-01-01 to 2025-03-31

11,052,000
Source

10-K · 2026-02-26 · 0001193125-26-073699

2025-01-01 to 2025-12-31

17,288,000
Source

10-K · 2025-03-05 · 0000950170-25-033510

2024-01-01 to 2024-12-31

17,186,000
Source

10-K · 2024-02-26 · 0000950170-24-020158

2023-01-01 to 2023-12-31

5,842,000
Source

10-K · 2023-02-28 · 0000950170-23-005067

2022-01-01 to 2022-12-31

Operating ExpensesUSD——36,476,000
Source

10-Q · 2025-11-13 · 0001193125-25-279096

2025-07-01 to 2025-09-30

55,451,000
Source

10-Q · 2025-11-13 · 0001193125-25-279096

2024-07-01 to 2024-09-30

33,216,000
Source

10-Q · 2026-08-13 · 0001193125-26-347988

2026-04-01 to 2026-06-30

38,875,000
Source

10-Q · 2026-08-13 · 0001193125-26-347988

2025-04-01 to 2025-06-30

34,299,000
Source

10-Q · 2026-05-13 · 0001193125-26-220696

2026-01-01 to 2026-03-31

42,909,000
Source

10-Q · 2026-05-13 · 0001193125-26-220696

2025-01-01 to 2025-03-31

154,350,000
Source

10-K · 2026-02-26 · 0001193125-26-073699

2025-01-01 to 2025-12-31

223,907,000
Source

10-K · 2025-03-05 · 0000950170-25-033510

2024-01-01 to 2024-12-31

254,044,000
Source

10-K · 2024-02-26 · 0000950170-24-020158

2023-01-01 to 2023-12-31

404,686,000
Source

10-K · 2023-02-28 · 0000950170-23-005067

2022-01-01 to 2022-12-31

Other General and Administrative ExpenseUSD——————————2,000,000
Source

10-K · 2024-02-26 · 0000950170-24-020158

2023-01-01 to 2023-12-31

—
Research and Development ExpenseUSD——25,838,000
Source

10-Q · 2025-11-13 · 0001193125-25-279096

2025-07-01 to 2025-09-30

34,650,000
Source

10-Q · 2025-11-13 · 0001193125-25-279096

2024-07-01 to 2024-09-30

24,387,000
Source

10-Q · 2026-08-13 · 0001193125-26-347988

2026-04-01 to 2026-06-30

27,430,000
Source

10-Q · 2026-08-13 · 0001193125-26-347988

2025-04-01 to 2025-06-30

24,703,000
Source

10-Q · 2026-05-13 · 0001193125-26-220696

2026-01-01 to 2026-03-31

29,136,000
Source

10-Q · 2026-05-13 · 0001193125-26-220696

2025-01-01 to 2025-03-31

107,829,000
Source

10-K · 2026-02-26 · 0001193125-26-073699

2025-01-01 to 2025-12-31

135,001,000
Source

10-K · 2025-03-05 · 0000950170-25-033510

2024-01-01 to 2024-12-31

172,596,000
Source

10-K · 2024-02-26 · 0000950170-24-020158

2023-01-01 to 2023-12-31

320,454,000
Source

10-K · 2023-02-28 · 0000950170-23-005067

2022-01-01 to 2022-12-31

Lines labelled “Derived” are calculated from reported figures.

Offerings

Registration 333-299862

S-3 · 2026-11-05 · 0001193125-26-450034

Terms from the governing filing for this registration; not a claim that the offering is open today.

Filing attachments

fate-ex99_1.htm · 8-K · 2026-11-05

Exhibit 99.1 Fate Therapeutics Reports Third Quarter 2026 Financial Results and Business Updates Safety profile presented at ASN Kidney Week 2026 across 29 autoimmune patients treated with a single dose of FT819 and fludarabine-free, less-intensive conditioning continues to be favorable, further supporting RECLAIM-LN Preliminary Phase 1 clinical data presented at ASN Kidney Week 2026 demonstrated 100% renal response in the bendamustine conditioning regimen selected for RECLAIM-LN $15.0 milli…

8-K · 2026-11-05 · 0001193125-26-448530

Read attachment ↗
fate-ex99_1.htm · 8-K · 2026-09-28

Exhibit 99.1 Fate Therapeutics Announces Receipt of California Institute for Regenerative Medicine (CIRM) CLIN2 Grant to Advance RECLAIM-LN $15.0 Million Award to Support Advancement of RECLAIM-LN, a Phase 2 Potentially Registrational Trial of FT819 Off-the-Shelf CAR T-Cell Therapy in Lupus Nephritis CLIN2 Grant is a highly competitive award from CIRM to fund advancing clinical trials for stem cell and gene therapies that have the potential to provide transformative benefits to patients and t…

8-K · 2026-09-28 · 0001193125-26-403429

Read attachment ↗
fate-ex99_1.htm · 8-K · 2026-08-13

EX-99.1 2 fate-ex99_1.htm EX-99.1 EX-99.1 Exhibit 99.1 Fate Therapeutics Reports Second Quarter 2026 Financial Results and Business Updates First lupus nephritis patient dosed in RECLAIM-LN, a Phase 2 potentially registrational trial utilizing FT819, an iPSC-derived, off-the-shelf CAR T-cell therapy; patient was treated as an outpatient with same-day discharge FDA clearance of the FT839 IND application advances the Company’s novel dual CD19/CD38 targeting off-the-shelf CAR T-cell product…

8-K · 2026-08-13 · 0001193125-26-347984

Read attachment ↗
d83385dex991.htm · 8-K · 2026-06-04

EX-99.1 2 d83385dex991.htm EX-99.1 EX-99.1 Exhibit 99.1 TRANSFORMING THE LIVES OF PATIENTS LIV ING WITH AUTOIMMUN E DISEASES AND C ANCER Making Cell Therapies Accessible to AllTM CORPORATE PRESENTATION June 2026 | NASDAQ: FATE | Non-Confidential © 2026 Fate Therapeutics. All rights reserved Forward-Looking Statements This presentation contains “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995, including statements regarding the safety …

8-K · 2026-06-04 · 0001193125-26-257558

Read attachment ↗
fate-ex99_1.htm · 8-K · 2026-05-13

EX-99.1 2 fate-ex99_1.htm EX-99.1 EX-99.1 Exhibit 99.1 Fate Therapeutics Reports First Quarter 2026 Financial Results and Business Updates RECLAIM - LN, a Phase 2 potentially registrational clinical trial of FT819 in patients with refractory moderate-to-severe systemic lupus erythematosus (SLE) with lupus nephritis, on schedule to initiate in the 2nd half of 2026 FDA selects FT819 into the CDRP (CMC Development and Readiness Pilot) program enabling early and enhanced communication with t…

8-K · 2026-05-13 · 0001193125-26-220691

Read attachment ↗
fate-ex4_4.htm · 10-K · 2026-02-26

Exhibit 4.4 DESCRIPTION OF THE REGISTRANT’S SECURITIES REGISTERED PURSUANT TO SECTION 12 OF THE SECURITIES EXCHANGE ACT OF 1934 As of the date of this Annual Report on Form 10-K of which this exhibit forms a part, Fate Therapeutics, Inc. (the “Company,” “we,” “us,” and “our”) had one class of securities registered under Section 12 of the Securities Exchange Act of 1934, as amended: our Common Stock (as defined below). DESCRIPTION OF CAPITAL STOCK The following description of our Common Sto…

10-K · 2026-02-26 · 0001193125-26-073699

Read attachment ↗

Privacy choices

BCS measures page use with Google Analytics using regional consent settings. You can change your preference here. Charts and market data remain available.

Essential functions — always available. Security, navigation, registration and remembering these choices.

Audience analytics

Analytics cookies are off by default for visitors Google identifies in the EEA, UK or Switzerland until allowed. Limited measurement without analytics cookies may still occur under those regional defaults.

TradingView charts, quotes and the economic calendar load automatically as page content. TradingView receives network and browser information and may collect its own usage analytics. This choice controls BCS’s Google Analytics only.

Google advertising is not enabled. Direct sponsor links do not load advertising trackers on BCS.

Turning analytics off stops future Google Analytics activity here. It does not erase information already received by the provider. Read the privacy policy.